In 2005, in a study by Rossi et al., 83 cases of lung LCNEC (65% metastatic patients) were analyzed, aiming to explore clinical and therapeutic histories and to identify new potential therapeutic targets and better strategies for treatment by performing immunohistochemical screening for several tyrosine kinase receptors [19]. This evidence concerns the gene NTRK1 and medical procedure.